Oliver Lagore Vanvalin Investment Group’s VanEck Semiconductor ETF SMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.19M Buy
+5,608
New +$1.3M 0.47% 53
2024
Q4
$1.2M Buy
4,940
+140
+3% +$34.7K 0.31% 66
2024
Q3
$1.18M Buy
4,800
+4,786
+34,186% +$1.16M 0.32% 64
2024
Q2
$3.65K Hold
14
﹤0.01% 538
2024
Q1
$3.15K Buy
+14
New +$2.81K ﹤0.01% 574
2023
Q1
Sell
-182
Closed -$18.6K 732
2022
Q4
$18.6K Sell
182
-370
-67% -$37.6K 0.01% 285
2022
Q3
$51K Sell
552
-132
-19% -$14.4K 0.03% 166
2022
Q2
$70K Sell
684
-12
-2% -$1.39K 0.04% 152
2022
Q1
$94K Buy
+696
New +$95.3K 0.06% 133

Other funds holding SMH

Oliver Lagore Vanvalin Investment Group's SMH Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in VanEck Semiconductor ETF (SMH) in Q2 2025: 5,608 shares worth $1.19M. The stake represents 0.47% of the portfolio and ranks #53 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in SMH as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in SMH in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.2M in Q4 2024. 1,017 funds tracked by Wall St. Rank hold SMH as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 5,608 shares of VanEck Semiconductor ETF worth $1.19M as of Q2 2025.
  • VanEck Semiconductor ETF was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • VanEck Semiconductor ETF made up 0.47% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #53 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in VanEck Semiconductor ETF in Q1 2022 and has held it in 9 quarters since.
  • Oliver Lagore Vanvalin Investment Group's VanEck Semiconductor ETF position peaked at $1.2M in Q4 2024.
  • 1,017 funds tracked by Wall St. Rank held VanEck Semiconductor ETF as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.